Search results for "antibiotic resistance"

showing 10 items of 243 documents

Antibiotics and Environment.

2020

Since the discovery of penicillin by Alexander Fleming in 1928, the use of antibiotics has become the golden standard in the treatment of bacterial infections of all kinds [...]

Microbiology (medical)endocrine systemmedicine.medical_specialtymedicine.drug_classbusiness.industryanimal diseaseslcsh:RM1-950AntibioticsBiochemistryMicrobiologyAntibiotics antibiotic resistance environmentPenicillinn/alcsh:Therapeutics. PharmacologyInfectious DiseasesAntibiotic resistanceEditorialmedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsIntensive care medicinebusinesshuman activitiesmedicine.drugAntibiotics (Basel, Switzerland)
researchProduct

Colonization Resistance of the Gut Microbiota against Clostridium difficile

2015

Antibiotics strongly disrupt the human gut microbiota, which in consequence loses its colonization resistance capacity, allowing infection by opportunistic pathogens such as Clostridium difficile. This bacterium is the main cause of antibiotic-associated diarrhea and a current problem in developed countries, since its incidence and severity have increased during the last years. Furthermore, the emergence of antibiotic resistance strains has reduced the efficiency of the standard treatment with antibiotics, leading to a higher rate of relapses. Here, we review recent efforts focused on the impact of antibiotics in the gut microbiome and their relationship with C. difficile colonization, as w…

Microbiology (medical)medicine.drug_classAntibioticsReviewColonisation resistanceBiologyGut floradigestive systemBiochemistryMicrobiologyantibioticsMicrobiologyAntibiotic resistancecolonization resistancemedicinePharmacology (medical)ColonizationGeneral Pharmacology Toxicology and PharmaceuticsPathogenlcsh:RM1-950Clostridium difficileClostridium difficileAntimicrobialbiology.organism_classificationlcsh:Therapeutics. PharmacologyInfectious Diseasesgut microbiota restorationAntibiotics
researchProduct

Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases …

2013

Antibiotics and antibiotic resistance determinants, natural molecules closely related to bacterial physiology and consistent with an ancient origin, are not only present in antibiotic-producing bacteria. Throughput sequencing technologies have revealed an unexpected reservoir of antibiotic resistance in the environment. These data suggest that co-evolution between antibiotic and antibiotic resistance genes has occurred since the beginning of time. This evolutionary race has probably been slow because of highly regulated processes and low antibiotic concentrations. Therefore to understand this global problem, a new variable must be introduced, that the antibiotic resistance is a natural even…

Microbiology (medical)medicine.drug_classAntibioticslcsh:QR1-502Review ArticleBiologyDiversification (marketing strategy)medicine.disease_causeMicrobiologyEnvironmental resistomelcsh:Microbiologyreview.03 medical and health sciencesPlasmidAntibiotic resistancemedicine030304 developmental biologyOXA-beta-lactamase2. Zero hungerGenetics0303 health sciencesResistance (ecology)030306 microbiologyMechanism (biology)Pathogenic bacteriaβ-lactamase3. Good healthResistomeintrinsic resistomeEvolutionary biologyplasticity-lactamase
researchProduct

Do We Know When, What and For How Long to Treat?

2012

Community-acquired pneumonia (CAP) is a common cause of morbidity among children in developed countries and accounts for an incidence of 10-40 cases per 1000 children in the first 5 years of life. Given the clinical, social and economic importance of CAP, there is general agreement that prompt and adequate therapy is essential to reduce the impact of the disease. The aim of this discussion paper is to consider critically the available data concerning the treatment of uncomplicated pediatric CAP and to consider when, how and for how long it should be treated. This review has identified the various reasons that make it difficult to establish a rational approach to the treatment of pediatric C…

Microbiology (medical)medicine.medical_specialtyRespiratory tract infectionsbusiness.industryRespiratory infectionDiseasemedicine.diseasePneumoniaInfectious DiseasesAntibiotic resistanceCommunity-acquired pneumoniaPediatrics Perinatology and Child HealthEpidemiologymedicineEtiologybusinessIntensive care medicinePediatric Infectious Disease Journal
researchProduct

Learning From Mistakes: The Role of Phages in Pandemics

2021

The misuse of antibiotics is leading to the emergence of multidrug-resistant (MDR) bacteria, and in the absence of available treatments, this has become a major global threat. In the middle of the recent severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic, which has challenged the whole world, the emergence of MDR bacteria is increasing due to prophylactic administration of antibiotics to intensive care unit patients to prevent secondary bacterial infections. This is just an example underscoring the need to seek alternative treatments against MDR bacteria. To this end, phage therapy has been proposed as a promising tool. However, further research in the field is mandatory to assure…

Microbiology (medical)medicine.medical_specialtyantibiotic resistancephage therapyPhage therapyPhage therapymedicine.drug_classMultidrug-resistant bacteriamedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibioticslcsh:QR1-502multidrug-resistant bacteriaEmergent pathogenMicrobiologylcsh:Microbiologylaw.inventionAntibiotic resistancelawPandemicmedicineIntensive care medicinePublic healthbusiness.industryTreatment regimenPublic healthpublic healthIntensive care unitemergent pathogenPerspectivebusinessFrontiers in Microbiology
researchProduct

Adapting a Phage to Combat Phage Resistance

2020

Phage therapy is becoming a widely recognized alternative for fighting pathogenic bacteria due to increasing antibiotic resistance problems. However, one of the common concerns related to the use of phages is the evolution of bacterial resistance against the phages, putatively disabling the treatment. Experimental adaptation of the phage (phage training) to infect a resistant host has been used to combat this problem. Yet, there is very little information on the trade-offs of phage infectivity and host range. Here we co-cultured a myophage FCV-1 with its host, the fish pathogen Flavobacterium columnare, in lake water and monitored the interaction for a one-month period. Phage resistance was…

Microbiology (medical)phage therapyGLIDING MOTILITYPhage therapyvirusesmedicine.medical_treatmentevoluutioVirulencefish pathogenmedicine.disease_causeBiochemistryMicrobiologyGenomebakteriofagitArticleMicrobiologyBacteriophage03 medical and health sciencesAntibiotic resistancemedicineCRISPRPharmacology (medical)General Pharmacology Toxicology and Pharmaceutics030304 developmental biology11832 Microbiology and virologyInfectivitylääkeresistenssi0303 health sciencesPREDATIONPRODUCTIVITYbiology030306 microbiologylcsh:RM1-950ARMS-RACEPathogenic bacteriakalatauditbiology.organism_classificationEVOLUTIONfagiterapialcsh:Therapeutics. PharmacologyInfectious Diseasesphage resistancecoevolution1182 Biochemistry cell and molecular biologyVIRULENCEHOST-RANGEBACTERIOPHAGEAntibiotics
researchProduct

Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant Salmonella enterica and Methicill…

2020

Background: Antimicrobial resistance (AMR) thwarts the curative power of drugs and is a present-time global problem. We present data on antimicrobial susceptibility and resistance determinants of bacteria the WHO has highlighted as being key antimicrobial resistance concerns in Africa, to strengthen knowledge of AMR patterns in the region. Methods: Blood, stool, and urine specimens of febrile patients, aged between ≥ 30 days and ≤ 15 years and hospitalized in Burkina Faso, Gabon, Ghana, and Tanzania were cultured from November 2013 to March 2017 (Patients > 15 years were included in Tanzania). Antimicrobial susceptibility testing was performed for all Enterobacterales and Staphylococcus aur…

Microbiology (medical)sub-Saharan AfricaSalmonellaextended-spectrum beta-lactamase-(ESBL)Klebsiella pneumoniaemedicine.medical_treatmentlcsh:QR1-502Biologymethicillin-resistant Staphylococcus aureusmedicine.disease_causeMicrobiologylcsh:MicrobiologyMicrobiology03 medical and health sciencesAntibiotic resistanceEnterobacteralesparasitic diseasesmedicineantimicrobial resistanceOriginal Research030304 developmental biologyfever0303 health sciences030306 microbiologySalmonella entericabiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesMethicillin-resistant Staphylococcus aureusStaphylococcus aureusSalmonella entericaBeta-lactamaseMultilocus sequence typingFrontiers in microbiology
researchProduct

Targeting the Class A Carbapenemase GES-5 via Virtual Screening

2020

The worldwide spread of &beta

Models MolecularDrugantibiotic resistanceGES-5Antibiotic resistancemedia_common.quotation_subjectIn silicoDrug Evaluation Preclinicallcsh:QR1-502Guyana extended-spectrum-β-lactamaseMicrobial Sensitivity TestsComputational biologyBiologyBiochemistrybeta-LactamasesArticlelcsh:Microbiologyguyana extended-spectrum-β-lactamasecarbapenemase03 medical and health sciencesAntibiotic resistanceBacterial ProteinsDrug Resistance BacterialHumansAntibiotic resistance; GES-5; Guyana extended-spectrum-β-lactamase; carbapenemase; virtual screening; docking; noncovalent inhibitionges-5noncovalent inhibitionMolecular Biology030304 developmental biologymedia_common0303 health sciencesVirtual screening030306 microbiologyAntibiotic resistance; Carbapenemase; Docking; GES-5; Guyana extended-spectrum-β-lactamase; Noncovalent inhibition; Virtual screeningHit to leadvirtual screeningAntimicrobialAnti-Bacterial AgentsCarbapenemsdockingBiomolecules
researchProduct

Estimation of the Amount of Disposed Antibiotics

2019

The impact of the antibiotics in the environment is not well understood yet. Moreover, the total amount of antibiotics that are ending up in the environment as solid waste is not known and cannot be rigorously determined as many variables are influencing the determination of their concentration. The present article is focused on the estimation of the amount of non-prescribed antibiotics that are used in different European countries. Particular attention is paid to the class of beta-lactams, as they are responsible for a considerate share of the antimicrobial resistance. The primary purpose was the estimation of the quantity of non-prescribed antibiotics that might reach the environment as s…

Municipal solid wastemedicine.drug_classGeography Planning and DevelopmentAntibioticsTJ807-830010501 environmental sciencesManagement Monitoring Policy and LawTD194-19501 natural sciencesantibiotics disposalRenewable energy sources03 medical and health sciencesAntibiotic resistancemedicineGE1-3500105 earth and related environmental sciencesEstimation0303 health sciencesEnvironmental effects of industries and plants030306 microbiologyRenewable Energy Sustainability and the Environmentbusiness.industryBiotechnologyEnvironmental sciencessolid-wastebusinessnon-prescribed antibioticsSustainability
researchProduct

Coordinate overexpression of two RND efflux systems, ParXY and TtgABC , is responsible for multidrug resistance in Pseudomonas putida

2020

Resistance Nodulation cell Division (RND) efflux pumps are known to contribute to the tolerance of Pseudomonas putida to aromatic hydrocarbons, but their role in antibiotic resistance has not been fully elucidated. In this study, two types of single-step multidrug-resistant (MDR) mutants were selected in vitro from reference strain KT2440. Mutants of the first type were more resistant to fluoroquinolones and β-lactams except imipenem, and overproduced the efflux system TtgABC as a result of mutations occurring in regulator TtgR. In addition to TtgABC, mutants of the second type such as HPG-5 were found to upregulate a novel RND pump, dubbed ParXY/TtgC, which accommodates cefepim, fluoroquin…

MutantGlyoxylate cycleMicrobial Sensitivity Testsmedicine.disease_causeMicrobiologyMicrobiology03 medical and health sciencesAntibiotic resistanceBacterial ProteinsDrug Resistance Multiple BacterialmedicineGeneEcology Evolution Behavior and SystematicsComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesMutationbiology030306 microbiologyPseudomonas putidaMembrane Transport ProteinsBiological TransportGene Expression Regulation Bacterialbiology.organism_classificationPseudomonas putidaAnti-Bacterial AgentsMultiple drug resistance[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMutationEffluxCell Division
researchProduct